FAIRCHEMOR Stock Overview
Manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, North America, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Fairchem Organics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹782.00 |
52 Week High | ₹1,553.00 |
52 Week Low | ₹775.00 |
Beta | -0.15 |
11 Month Change | -29.15% |
3 Month Change | -44.13% |
1 Year Change | -33.71% |
33 Year Change | -56.01% |
5 Year Change | n/a |
Change since IPO | 20.19% |
Recent News & Updates
Benign Growth For Fairchem Organics Limited (NSE:FAIRCHEMOR) Underpins Stock's 26% Plummet
Nov 15Capital Investments At Fairchem Organics (NSE:FAIRCHEMOR) Point To A Promising Future
Oct 09We Discuss Why Fairchem Organics Limited's (NSE:FAIRCHEMOR) CEO Compensation May Be Closely Reviewed
Jul 30Recent updates
Benign Growth For Fairchem Organics Limited (NSE:FAIRCHEMOR) Underpins Stock's 26% Plummet
Nov 15Capital Investments At Fairchem Organics (NSE:FAIRCHEMOR) Point To A Promising Future
Oct 09We Discuss Why Fairchem Organics Limited's (NSE:FAIRCHEMOR) CEO Compensation May Be Closely Reviewed
Jul 30Fairchem Organics (NSE:FAIRCHEMOR) Has Announced A Dividend Of ₹7.50
Jul 26Fairchem Organics' (NSE:FAIRCHEMOR) Dividend Will Be ₹7.50
Jul 12Fairchem Organics (NSE:FAIRCHEMOR) Has Affirmed Its Dividend Of ₹7.50
Jun 19Fairchem Organics (NSE:FAIRCHEMOR) Has Announced A Dividend Of ₹7.50
May 30Fairchem Organics (NSE:FAIRCHEMOR) Has A Pretty Healthy Balance Sheet
Mar 13Fairchem Organics' (NSE:FAIRCHEMOR) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 29Fairchem Organics (NSE:FAIRCHEMOR) Is Paying Out Less In Dividends Than Last Year
Jul 15Fairchem Organics' (NSE:FAIRCHEMOR) Dividend Will Be Reduced To ₹7.50
Jun 02Under The Bonnet, Fairchem Organics' (NSE:FAIRCHEMOR) Returns Look Impressive
Apr 26Fairchem Organics Limited's (NSE:FAIRCHEMOR) Popularity With Investors Is Under Threat From Overpricing
Feb 08Fairchem Organics (NSE:FAIRCHEMOR) Is Very Good At Capital Allocation
Nov 01We Think You Should Be Aware Of Some Concerning Factors In Fairchem Organics' (NSE:FAIRCHEMOR) Earnings
May 25Investors Shouldn't Overlook Fairchem Organics' (NSE:FAIRCHEMOR) Impressive Returns On Capital
Jan 10Shareholder Returns
FAIRCHEMOR | IN Chemicals | IN Market | |
---|---|---|---|
7D | -10.3% | -0.8% | 0.5% |
1Y | -33.7% | 10.7% | 27.5% |
Return vs Industry: FAIRCHEMOR underperformed the Indian Chemicals industry which returned 9.6% over the past year.
Return vs Market: FAIRCHEMOR underperformed the Indian Market which returned 25.5% over the past year.
Price Volatility
FAIRCHEMOR volatility | |
---|---|
FAIRCHEMOR Average Weekly Movement | 5.8% |
Chemicals Industry Average Movement | 5.6% |
Market Average Movement | 6.1% |
10% most volatile stocks in IN Market | 9.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: FAIRCHEMOR has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: FAIRCHEMOR's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | 227 | Nahoosh Jariwala | www.fairchem.in |
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, North America, and internationally. It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, isostearic, monobasic, linoleic/soya fatty, monomer, stearic, palmitic, and distilled fatty acid products, as well as residues. The company was incorporated in 2019 and is based in Ahmedabad, India.
Fairchem Organics Limited Fundamentals Summary
FAIRCHEMOR fundamental statistics | |
---|---|
Market cap | ₹10.18b |
Earnings (TTM) | ₹419.55m |
Revenue (TTM) | ₹6.12b |
24.3x
P/E Ratio1.7x
P/S RatioIs FAIRCHEMOR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FAIRCHEMOR income statement (TTM) | |
---|---|
Revenue | ₹6.12b |
Cost of Revenue | ₹4.51b |
Gross Profit | ₹1.61b |
Other Expenses | ₹1.19b |
Earnings | ₹419.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
Earnings per share (EPS) | 32.22 |
Gross Margin | 26.35% |
Net Profit Margin | 6.85% |
Debt/Equity Ratio | 14.9% |
How did FAIRCHEMOR perform over the long term?
See historical performance and comparison